Journal of Nuclear Medicine

Aims & Scope

The Journal of Nuclear Medicine (JNM)—self-published by the Society of Nuclear Medicine and Molecular Imaging (SNMMI), a nonprofit, international scientific and professional organization—offers readers around the globe clinical investigations, basic science reports, continuing education articles, book reviews, employment opportunities, and updates on rapidly changing issues in practice and research.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	9.1
2024	9.10

SJR (SCImago Journal Rank)

Year	Value
2024	2.224

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	247

Journal Rank

Year	Value
2024	1176

Journal Citation Indicator

Year	Value
2024	6738

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors

  Citation: 2996

  Authors: Richard L., Heather, Yvette, Martin A.

• Introduction to Radiomics

  Citation: 1293

  Authors: Marius E., Andrzej, Georg, Ida, Piotr, Peter, Gary

• Partial-Volume Effect in PET Tumor Imaging

  Citation: 1250

  Authors: M., S. L., I.

• ⁶⁸Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer

  Citation: 1175

  Authors: Clemens, Paul, Thomas, Labidi, Annette, Walter, Sebastian, Hendrik, Manuel, Hauke, Peter K., Frederik, Matthias, Hans-Ulrich, Dirk, Jürgen, Uwe, Frederik L.

• Recommendations on the Use of ¹⁸F-FDG PET in Oncology

  Citation: 916

  Authors: James W., Benjamin, Heloisa P., Barry A., Val J., Gary H., R. Edward, Richard, John Christopher, Norbert, Lawrence H., W. Warren, David, Dominique, Mark, Anthony F.

• ²²⁵Ac-PSMA-617 for PSMA-Targeted α-Radiation Therapy of Metastatic Castration-Resistant Prostate Cancer

  Citation: 888

  Authors: Clemens, Frank, Frederik L., Mirjam, Frederik A., Felix, Klaus, Christos, Uwe, Alfred

• Evaluation of Hybrid ⁶⁸Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy

  Citation: 873

  Authors: Matthias, Tobias, Michael, Ambros J., Alexander, Bernhard, Frank-Philipp, Hubert, Uwe, Michael, Hans-Jürgen, Jürgen E., Markus

• 68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT

  Citation: 813

  Authors: M., C., D., G., D., C., P., E., R., I. J.

• Performance Measurements of the Siemens mMR Integrated Whole-Body PET/MR Scanner

  Citation: 757

  Authors: Gaspar, Sebastian, Björn, Ralf, Carl, Stephan G., Markus, Sibylle I.

• Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation Protein

  Citation: 727

  Authors: Thomas, Anastasia, Annette, Frederik, Clemens, Jürgen, Dirk, Walter, Uwe

---